VERA VERA THERAPEUTICS INC More: the full row for VERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 199,348 shares; 2026Q2: 600,836 shares; 2026Q3: 808,717 shares 808,717 $26.1M 6.85% +207,881 Timeline VOR VOR BIOPHARMA INC More: the full row for VOR BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,370,107 shares; 2026Q1: 1,750,000 shares; 2026Q2: 1,700,000 shares; 2026Q3: 1,126,910 shares 1,126,910 $21.5M 5.64% -573,090 Timeline AMLX AMYLYX PHARMACEUTICALS INC More: the full row for AMYLYX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,811,996 shares; 2025Q2: 2,000,000 shares; 2025Q3: 1,700,000 shares; 2025Q4: 1,750,000 shares; 2026Q1: 1,750,000 shares; 2026Q2: 700,000 shares; 2026Q3: 700,000 shares 700,000 $20.4M 5.35% 0 Timeline SGMT SAGIMET BIOSCIENCES INC More: the full row for SAGIMET BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,029,933 shares; 2026Q3: 1,961,701 shares 1,961,701 $19.4M 5.09% -68,232 Timeline DFTX DEFINIUM THERAPEUTICS INC More: the full row for DEFINIUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 425,000 shares; 2026Q3: 508,735 shares 508,735 $19.4M 5.08% +83,735 Timeline IONS IONIS PHARMACEUTICALS INC More: the full row for IONIS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 505,007 shares; 2025Q1: 250,000 shares; 2025Q2: 500,000 shares; 2025Q3: 80,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 420,000 shares 420,000 $18.8M 4.92% new Timeline GMAB GENMAB A/S More: the full row for GENMAB A/S Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 525,000 shares 525,000 $18.7M 4.92% new Timeline SLGL SOL-GEL TECHNOLOGIES LTD More: the full row for SOL-GEL TECHNOLOGIES LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 274,363 shares; 2026Q2: 274,363 shares; 2026Q3: 239,159 shares 239,159 $17.8M 4.66% -35,204 Timeline ZURA ZURA BIO LTD More: the full row for ZURA BIO LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,170,194 shares; 2025Q1: 3,170,194 shares; 2025Q2: 3,170,194 shares; 2025Q3: 3,815,930 shares; 2025Q4: 3,815,930 shares; 2026Q1: 4,215,930 shares; 2026Q2: 4,215,930 shares; 2026Q3: 4,077,256 shares 4,077,256 $17M 4.45% -138,674 Timeline LBRX LB PHARMACEUTICALS INC More: the full row for LB PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 300,000 shares; 2026Q2: 317,221 shares; 2026Q3: 410,420 shares 410,420 $15.8M 4.13% +93,199 Timeline ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,648,523 shares; 2025Q1: 1,638,111 shares; 2025Q2: 1,291,617 shares; 2025Q3: 150,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 204,314 shares; 2026Q3: 155,000 shares 155,000 $15.3M 4.03% -49,314 Timeline ANNX ANNEXON INC More: the full row for ANNEXON INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,500,000 shares; 2026Q2: 3,500,000 shares; 2026Q3: 3,500,000 shares 3,500,000 $14.8M 3.89% 0 Timeline BLTE BELITE BIO INC More: the full row for BELITE BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 75,000 shares 75,000 $12.7M 3.34% new Timeline EPRX EUPRAXIA PHARMACEUTICALS INC More: the full row for EUPRAXIA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,200,000 shares; 2025Q4: 1,200,000 shares; 2026Q1: 1,200,000 shares; 2026Q2: 1,200,000 shares; 2026Q3: 1,200,000 shares 1,200,000 $10.9M 2.87% 0 Timeline NKTR NEKTAR THERAPEUTICS More: the full row for NEKTAR THERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 300,000 shares; 2025Q4: 210,732 shares; 2026Q1: 316,453 shares; 2026Q2: 175,000 shares; 2026Q3: 175,000 shares 175,000 $10.6M 2.78% 0 Timeline MLTX MOONLAKE IMMUNOTHERAPEUTICS More: the full row for MOONLAKE IMMUNOTHERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 500,000 shares; 2026Q2: 855,813 shares; 2026Q3: 855,813 shares 855,813 $10M 2.63% 0 Timeline CLYM CLIMB BIO INC More: the full row for CLIMB BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 979,534 shares; 2026Q1: 1,334,130 shares; 2026Q2: 1,000,000 shares; 2026Q3: 800,000 shares 800,000 $9.18M 2.41% -200,000 Timeline ABCL ABCELLERA BIOLOGICS INC More: the full row for ABCELLERA BIOLOGICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 600,000 shares 600,000 $8.75M 2.3% new Timeline NGNE NEUROGENE INC More: the full row for NEUROGENE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 442,761 shares; 2025Q1: 470,964 shares; 2025Q2: 485,859 shares; 2025Q3: 446,814 shares; 2025Q4: 350,000 shares; 2026Q1: 500,000 shares; 2026Q2: 352,180 shares; 2026Q3: 300,000 shares 300,000 $8.35M 2.19% -52,180 Timeline CMPS COMPASS PATHWAYS PLC More: the full row for COMPASS PATHWAYS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 500,000 shares 500,000 $6.22M 1.63% new Timeline JATT JATT II ACQUISITION CORP More: the full row for JATT II ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 500,000 shares; 2026Q3: 500,000 shares 500,000 $5.62M 1.48% 0 Timeline IFRX INFLARX NV More: the full row for INFLARX NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,046,557 shares; 2026Q3: 3,046,557 shares 3,046,557 $5.48M 1.44% 0 Timeline RACC RESEARCH ALLIANCE CORP III More: the full row for RESEARCH ALLIANCE CORP III Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 504,891 shares 504,891 $5.47M 1.44% new Timeline DRUG BRIGHT MINDS BIOSCIENCES INC More: the full row for BRIGHT MINDS BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 220,000 shares; 2026Q2: 109,603 shares; 2026Q3: 109,603 shares 109,603 $5.46M 1.43% 0 Timeline AMAN AMANAT ACQUISITION CORP More: the full row for AMANAT ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 500,000 shares; 2026Q3: 500,000 shares 500,000 $5.34M 1.4% 0 Timeline ALT ALTIMMUNE INC More: the full row for ALTIMMUNE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,741,232 shares; 2026Q3: 1,741,232 shares 1,741,232 $4.98M 1.31% 0 Timeline JTTT JATT III ACQUISITION CORP More: the full row for JATT III ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 450,000 shares 450,000 $4.96M 1.3% new Timeline SCYX SCYNEXIS INC More: the full row for SCYNEXIS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 944,292 shares; 2026Q3: 944,292 shares 944,292 $4.66M 1.22% 0 Timeline CGEM CULLINAN THERAPEUTICS INC More: the full row for CULLINAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 634,032 shares; 2026Q1: 300,000 shares; 2026Q2: 300,000 shares; 2026Q3: 300,000 shares 300,000 $4.61M 1.21% 0 Timeline HELP CYBIN INC More: the full row for CYBIN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 320,952 shares 320,952 $3.94M 1.04% new Timeline RZLT REZOLUTE INC More: the full row for REZOLUTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 621,894 shares; 2025Q1: 833,042 shares; 2025Q2: 3,033,462 shares; 2025Q3: 2,451,809 shares; 2025Q4: 951,809 shares; 2026Q1: 951,809 shares; 2026Q2: 951,809 shares; 2026Q3: 951,809 shares 951,809 $3.94M 1.03% 0 Timeline IRD OPUS GENETICS INC More: the full row for OPUS GENETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 324,340 shares; 2026Q2: 1,970,187 shares; 2026Q3: 776,881 shares 776,881 $3.76M 0.99% -1,193,306 Timeline ELVN ENLIVEN THERAPEUTICS INC More: the full row for ENLIVEN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 70,000 shares; 2026Q3: 70,000 shares 70,000 $3.21M 0.84% 0 Timeline RLMD RELMADA THERAPEUTICS INC More: the full row for RELMADA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 842,106 shares; 2026Q2: 842,106 shares; 2026Q3: 842,106 shares 842,106 $3.17M 0.83% 0 Timeline DBVT DBV TECHNOLOGIES S A More: the full row for DBV TECHNOLOGIES S A Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 374,679 shares; 2025Q3: 378,594 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 156,906 shares; 2026Q3: 250,000 shares 250,000 $2.94M 0.77% +93,094 Timeline EVMN EVOMMUNE INC More: the full row for EVOMMUNE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 325,000 shares; 2026Q1: 325,000 shares; 2026Q2: 325,000 shares; 2026Q3: 325,000 shares 325,000 $2.68M 0.7% 0 Timeline CTNM CONTINEUM THERAPEUTICS INC More: the full row for CONTINEUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 800,000 shares; 2026Q1: 800,198 shares; 2026Q2: 921,481 shares; 2026Q3: 186,183 shares 186,183 $2.5M 0.66% -735,298 Timeline ORKA ORUKA THERAPEUTICS INC More: the full row for ORUKA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 228,803 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 183,330 shares; 2025Q4: 183,330 shares; 2026Q1: 183,330 shares; 2026Q2: 183,330 shares; 2026Q3: 24,649 shares 24,649 $2.05M 0.54% -158,681 Timeline HUMA HUMACYTE INC More: the full row for HUMACYTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,750,000 shares; 2026Q2: 3,750,000 shares; 2026Q3: 3,750,000 shares 3,750,000 $1.94M 0.51% 0 Timeline RNTX REIN THERAPEUTICS INC More: the full row for REIN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,575,000 shares; 2026Q3: 1,663,144 shares 1,663,144 $1.34M 0.35% -911,856 Timeline RACD RESEARCH ALLIANCE CORP IV More: the full row for RESEARCH ALLIANCE CORP IV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 106,396 shares 106,396 $1.28M 0.34% new Timeline